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Abstract 
Background: The spectrum of infective endocarditis (IE) is significantly different in 
developed and developing countries.  The present study was conducted to study the clinical 
profile and outcome of infective endocarditis in Pakistan.    
 
Methods:  A descriptive cross-sectional study with review of medical records for 188 
patients admitted to our teaching hospital with a diagnosis of IE from January 1988 to 
December 2001.  One hundred fifty-nine subjects fulfilled the modified Duke diagnostic 
criteria.   
 
Results: Definite IE was found in 59.7% (95/159) patients, while the rest had possible IE.  
One-third of subjects had acute IE 55/159 (34.5%). Subacute IE was found in 62% (99/159) 
and Nosocomial IE in 3% of the cases.  Eighty six (54%) were classified as having culture-
negative endocarditis and 73 (46%) as culture positive.  Ninty four patients (59%) had an 
underlying predisposing factor including congenital heart disease (31%) and rheumatic heart 
disease (21%).  The most frequently isolated organisms were streptococci (52%) and 
followed by staphylococci (29%).  Fourteen (8.1%) patients had right-sided cardiac 
involvement.  Using univariate analysis, patients with heart failure, neurologic or renal 
complications, septicemia, nosocomial endocarditis, and prosthetic valve endocarditis were at 
increased risk of death (p ≤ 0.05), however no individual microorganism, or specific site, 
size, or morphology of vegetation seen on echocardiogram were significantly associated with 
death. Thirty-seven (23%) patients died of endocarditis or its complications.       
 
Conclusion:  Endocarditis continues to be an important contributor to morbidity and 
mortality in Pakistan, especially in young adults. Our patients differ from the west in terms of 
epidemiology, predisposing factors, microbiology, complications, and outcome. 
 
Keywords:  Infective endocarditis, Pakistan, Epidemiology, Microbiology, Complications, 
Outcome 
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Introduction 
The epidemiology, clinical, and microbiologic spectrum of infective endocarditis (IE) is 
significantly different in the developing countries compared to the western world.                 
These differences can be attributable to multiple factors present in poorer countries including 
significantly higher incidences of rheumatic heart disease and uncorrected congenital heart 
disease, excessive and improper use of antibiotics, late clinical presentation, and worse 
outcomes.1,2 In addition, developing countries may have a higher incidence of ‘culture 
negative endocarditis’ than in the west, largely secondary to prior doctor-prescribed or self-
administered antibiotic use3,4, and life-threatening complications from IE are still common 
despite echocardiographic diagnosis and use of effective antibiotics.5  
 
There is a paucity of published reports about IE from developing regions of the world5,6, and 
there are no large case series from centers involved in cardiac intervention and surgery.  In 
light of the changing global trends in endocarditis over the last four decades, further insight 
into the clinical expression of the disease in developing countries and a comparison with 
western data is warranted.  The authors have previously conducted the first case series of 
endocarditis from Pakistan. The study showed that life-threatening complications from 
endocarditis are still common despite the use of effective antibiotics and echocardiographic 
diagnosis.5 Herein, we present one of the largest case series on IE from the Indian 
subcontinent 
 
Patients and Methods 
We reviewed the medical records of all patients admitted to the Aga Khan University 
Hospital in Karachi, Pakistan with a diagnosis of IE during the period, January 1988 through 
December 2001. The Aga Khan University Hospital is a tertiary care hospital serving more 
than 10 million people of the city, the surrounding province of Sindh, and elsewhere 
throughout Pakistan.  The patient population includes a large number of immigrants from 
around the country and referrals from underserved rural areas where rheumatic heart disease 
and undetected congenital heart disease are very common. The mean number of medical adult 
medicine and pediatric admissions during the study period was more than 13,000 patients 
annually.   
 
The search was made through electronically-coded medical records and the echocardiography 
logbook maintained by the Cardiac Diagnostic Laboratory. One hundred and eighty-eight 
patients were identified with suspected endocarditis. Of these, 159 patients fulfilled the 
modified Duke criteria7, and were included in the final analysis.  We used the modified Duke 
criteria in order to validate our results.  Cases were defined clinically as “definite” if they 
fulfilled two of the Duke major criteria, one major plus three minor criteria, or five minor 
criteria; they were defined as “possible” if they fulfilled one major plus one minor criteria, or 
three minor criteria.  “Acute” endocarditis was defined as beginning suddenly with a high 
fever (102° to 104°F [38.9° to 40°C]), fast heart rate, fatigue, and rapid and extensive heart 
valve damage.  “Subacute”endocarditis was defined as symptoms of fatigue, mild fever (99° 
to 101° F [37.2° to 38.3°C]), moderately fast heart rate, weight loss, sweating, a low red 
blood cell count, all generally occurring for months before diagnosis.  
The laboratory workup of the study group included: complete blood count, erythrocyte 
sedimentation rate, serum creatinine, serum electrolytes, urinalysis and  urine culture, chest x-
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ray, blood cultures (3-5 sets of aerobic and anaerobic bottles) drawn before the initiation of 
antibiotics, transthoracic echocardiography (TTE) and, if needed, transesophageal 
echocardiography (TEE). In cases with negative blood cultures, abdominal ultrasonography, 
and where appropriate, Mantoux skin testing and sputum for acid-fast bacilli smear and 
culture were performed.  In patients with fever and headache or with neurologic signs, 
cerebrospinal fluid examination and neuroimaging (computed tomography or magnetic 
resonance imaging) were conducted. In selected cases, an autoimmune profile was obtained.  
A peripheral blood smear looking for malarial parasites was performed in all subjects with 
unexplained fever.  Fungal blood cultures were sent in selected cases.  
 
Statistical analysis 
Statistical analysis of data was performed using the computerized software program SPSS 
version 13.0. Descriptive statistics were presented as percentages and as mean +/- standard 
deviation (SD). Univariate analysis was performed for prognostic factors of mortality using 
Pearson’s chi square test, Fischer’s exact test, or student’s t test, where appropriate. A p value 
of < 0.05 was considered statistically significant. 
 
Results 
General characteristics 
One hundred and fifty-nine patients with IE were identified according to the modified Duke 
criteria, and their general characteristics are shown in Table 1. The annual number of IE 
episodes during the study period was 0.87 per 1,000-hospital medical admissions. Mean 
patient age was 34 years + 21.2 SD (range, < 1 month to 87 years), and 34 (27%) patients 
were < 16 years of age.  The mean age for patients > 16 years was 42 +/- 16.7 (SD). The 
male: female ratio was 1.8:1. Nosocomial endocarditis was seen in five patients (3%). One-
third of subjects had acute endocarditis and the remainder had subacute IE. Of the 159 
subjects, 86 (54%) were classified as having culture-negative endocarditis and 73 (46%) as 
having culture-positive endocarditis. Sixty percent of patients had definitive endocarditis 
according to the Duke criteria while the rest had possible endocarditis. 
 
Underlying predisposing factors 
Overall, 94 patients (59%) had an underlying predisposing factor (Table 2).  Most commonly 
encountered risk factors included congenital heart disease (25%), most commonly a 
ventricular septal defect and rheumatic heart disease (21%).  Other important conditions were 
mitral valve prolapse with regurgitation (6%), prosthetic valve endocarditis (5%), and 
stenotic aortic valve disease (2%). Only one patient had documented history of intravenous 
drug use. Two patients were on dialysis with indwelling central catheters. 
 
Microbiology  
Causative microorganisms included streptococci (23%), staphylococci (13%; equally split 
between Staphylococcus aureus and Staphylococcus epidermidis), Gram-negative bacilli 
(5%), and Enterococcus faecalis (4%) (Table 3). Eighty-six subjects (54%) had no growth on 
multiple blood cultures and were thus classified as culture-negative IE. 
 
Echocardiography 
Echocardiography was performed in 155 of 159 (97%) patients: TTE in 152 (96%) and TEE 
in 20 (13%) patients. TTE was positive in 110 of 152 (72%) subjects and TEE in 15 of 20 
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subjects (75%). Fourteen (8%) patients had right-sided cardiac involvement.  The distribution 
of valves and other significant findings on echocardiography can be seen in Table 3. 
 
Treatment 
The antibiotic therapy used in our patients conformed in most cases to the guidelines of the 
American Heart Association for the treatment of IE. Sixty-eight percent of patients with   
streptococcal infections were treated with a combination of penicillin plus an aminoglycoside 
(gentamicin). The remainder received monotherapy with a beta-lactam or a glycopeptide  
(vancomycin or teicoplanin). Methicillin-sensitive staphylococci (62% of all staphylococci 
isolated) were treated with cloxacillin; subjects with methicillin-resistant Staphylococcus 
aureus (MRSA) or Staphylococcus epidermidis (MRSE) received vancomycin.  
Aminoglycosides were added for synergy in one-third of MRSA subjects, while rifampin was 
added in only one patient.  Sixty-eight percent of patients with culture-negative endocarditis 
received a combination containing at least one beta-lactam drug (penicillin G with or without 
cloxacillin) and an aminoglycoside; 12% patients also received vancomycin and 21% also 
received a 3rd-generation cephalosporin. All patients received 4-6 weeks of antimicrobial 
therapy.  Surgical intervention was required in 18 (11%) of the study group, with the most 
common indications being heart failure refractory to medical treatment, valve or myocardial 
abscess, prosthetic valve endocarditis, very large vegetations, systemic embolization, or IE 
refractory to medical treatment. 
 
Complications and outcome 
Complications occurred in about half of the study group and included neurologic (26%), 
cardiac (25%), renal (13%), hematologic (13%), embolic (10%), pneumonic (8%), and septic 
(4%) complications (Table 4). Thirty-seven (23%) patients died of IE or its complications.  
Mean patient follow-up was 3.5 months.  Twenty-one patients were lost to follow-up. 
 
Risk factors for mortality 
Table 5 demonstrates the risk factors for mortality using univariate analysis. In general, 
patients with neurological, cardiac, or renal complications or sepsis were at increased risk of 
dying. Nosocomial endocarditis was also associated with an increased mortality. No 
individual microorganism, or specific site, size, or morphology of vegetation seen on 
echocardiogram were significantly associated with death.  Patients with previous cardiac 
surgery, especially those with prosthetic valve endocarditis, were also at increased risk of 
death. 
 
Discussion 
This study represents one of the largest case series of IE reported from the Indian 
subcontinent, and our data confirm that IE continues to be an important cause of morbidity 
and mortality in Pakistan.  The spectrum of IE in our country differs from the west with 
respect to epidemiology, predisposing factors, microbiology, and outcome but is similar to 
that reported from neighboring India.8-12 
 
The young age of our study group (mean age, 34 years) is consistent with other studies from 
the region,9,10,13, but contrasts an older group (mean age 45-60 years) for patients with IE in 
the west.14-17 The reasons for this discrepancy are likely multifactorial and include a higher 
incidence of rheumatic heart disease and uncorrected congenital heart disease in poorer 
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countries like Pakistan, and a more aged population with a higher incidence of degenerative 
heart disease in the west.13,14,16   
 
We have previously reported on the impact of prior antibiotic use in culture-negative 
endocarditis.18 Prior antibiotic therapy before clinical presentation (seen in 52% of our study 
group) was the primary contributor to the high incidence (54%) of negative blood cultures in 
our series.  This incidence is consistent with the low yield from blood cultures, ranging from 
21 to 67%, reported from elsewhere on the subcontinent.5,6,10,13,14 In contrast, studies from 
industrialized counties report a diagnostic yield from blood cultures as high as 90% or 
more.13-16 Excessive antibiotic dispensing is common in developing countries; at least one 
antibiotic may be prescribed for 54%-62% of patients presenting to general practitioners in 
Pakistan.3,4 In addition, self-administration of antibiotics is commonplace in many developing 
countries where drugs are freely available and accessible without a prescription. As in the 
west, we assume that inadequate microbiologic techniques and infections with highly 
fastidious bacterial or non-bacterial microorganisms are other less likely reasons for negative 
blood cultures in our patients.  
 
The Duke and modified Duke criteria both depend on echocardiographic, microbiologic, and 
pathologic criteria and patients with clinically-suspected IE are classified as “definite”, 
“probable”, and “rejected” cases based upon these criteria.7 The degree of certainty of the 
diagnosis of IE often depends on the presence or absence of only one criterion.  The modified 
Duke diagnostic criteria are heavily based upon positive blood cultures, and a low 
microbiologic yield from blood culture raises questions as to the validity of these criteria in 
diagnosing culture-negative endocarditis in developing countries.17 More than 60% of our 
subjects with blood culture-negative endocarditis had ‘possible endocarditis’ according to the 
Duke criteria compared to < 15% of patients with positive blood cultures (p < 0.001, 95% CI 
0.07-0.3).  Furthermore, 29 patients diagnosed and treated for clinically presumptive IE were 
rejected from study entry according to the Duke criteria and negative blood cultures.  In a 
study of the individual value of each of the Duke criteria for the diagnosis of IE, Rognon and 
colleagues found that the major microbiologic criteria had the highest relative importance.19                 
Similarly, Tissieres and coworkers demonstrated the importance of positive blood cultures as 
a major IE criterion, with echocardiographic findings playing a less important role in 
diagnosis.20  A positive blood culture was the only criterion that differentiated “definite” from 
“possible” IE. Thus, for patients with clinically-suspected IE, but with persistently negative 
blood cultures (54% of our entire study cohort), the negative predictive value of the modified 
Duke criteria could be significantly compromised.    
 
During the 1990s, a significant change occurred in the microbiology of IE in the west. By the 
end of the decade, S aureus had overtaken viridans streptococci as the most frequently 
isolated pathogen, accounting for nearly 30-40% of cases.15,16,21 This microbiologic trend 
may be attributable to an aging population, more frequent intravenous drug use in the 
community, and an increased frequency of nosocomial, prosthetic valve, and iatrogenic 
endocarditis.  In contrast, rheumatic and congenital heart diseases account for the majority of 
our IE cases, prosthetic valve insertion is infrequently performed, and thus, streptococci still 
dominate our patient population, as in other studies from poorer countries.5,8,22 Previous 
studies have shown S aureus to be an independent predictor of mortality.15,16,21 We did not 
encounter an increased mortality in patients with S aureus IE, and this may be because 
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staphylococcal infection in the west is seen in different, high-risk patient populations, 
occurring in individuals with nosocomial, iatrogenic, hemodialysis-related or prosthetic valve 
infection.   
 
Like elsewhere on the Indian subcontinent, rheumatic heart disease and congenital heart 
disease continue to be the most important causes of IE in Pakistan. This is consistent with 
other studies from this part of the world.8-10 Right-sided endocarditis has a prevalence of 5-
10% in the west, and most of these cases are attributed to parenteral drug abuse.23,24 Fourteen 
(9%) of our patients had right-sided endocarditis but only one subject had a history of iv drug 
use. More than half of these patients had congenital heart disease and one-quarter had prior 
corrective cardiac surgery. Right-sided endocarditis in non-iv drug users has been previously 
reported from the Indian subcontinent and attributed to anatomic cardiac defects largely from 
congenital heart disease.25-27 These defects are generally corrected in early life in developed 
countries; usually in pre-school years and thus do not manifest as IE in later years. We found 
no particular microorganisms associated with right-sided endocarditis, in contrast to the west 
where S aureus and P. aureginosa are the major causes of tricuspid valve infection.23-24 
Unlike in the west where addict-associated IE generally has a better prognosis, subjects in our 
study cohort with right-sided endocarditis had no difference in mortality compared to patients 
with left-sided IE. They did, however, have fewer neurologic complications and peripheral 
emboli, and more pneumonia and larger vegetations.   
 
Studies from industrialized countries have shown a consistent improvement in survival of 
patients with IE over the past four decades, with mortality recently reported between             
15%–33%.11,14,28,29 A similar decrease in mortality is also seen in patients from the Indian 
subcontinent: 42% in 197012, 20.3% in 198110, 21%–25% in 19929,30, 13.9% in 199831, and 
13% in 20016.  The higher in-hospital mortality in our study (23%) may be explained by the 
fact that the Aga Khan University is a tertiary care referral center representing a skewed 
population of complicated cases.  We did not find valve site or vegetation size or morphology 
to significantly correlate with mortality, stroke, or peripheral embolism. As expected, 
prosthetic valve endocarditis, and neurologic, renal, cardiac, and peripheral complications 
were all associated with an increased risk of death.32-34 Other authors have observed similar 
associations with kidney and heart complications and prosthetic valve infection9,32,34,35, and in 
1992 Choudhry and colleagues reported from India that patients with neurologic 
complications had a higher incidence of death from IE.9  Others have also reported prosthetic 
valve endocarditis and systemic embolism as independent risk factors of mortality.33,35  
Death in five patients who developed IE >72 hrs in the hospital was very high (60%).  This is 
consistent with a recent series from Madrid, where nosocomial infection accounted for 22% 
of IE patients, and resulted in a very high mortality (>50%).36  These infections are often 
related to intravenous catheters or surgical procedures, and fewer than 50% of patients have 
underlying structural heart disease.16  
 
Our study has several limitations.  First, the ‘true’ microbiology of our cases could not be 
determined because many of the patients received prior antibiotic therapy prior to diagnosis, 
and because serology and polymerase chain reaction testing for fastidious organisms such as 
Brucella, Bartonella, Coxiella, and other rare causes of endocarditis were not performed.         
Second, only 20 patients (13%) underwent transesophageal echocardiography; the prevalence 
of culture-negative endocarditis may have increased if TEE had been performed on all 
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patients. Finally, being a tertiary care referral center our data may not truly represent 
endocarditis in the general community and may be skewed towards a sicker patient 
population, although they may be comparable to results from other academic centers.   
 
Conclusion 
In conclusion, endocarditis continues to be an important contributor to morbidity and 
mortality in Pakistan, especially among young adults. Our patients differ from those seen in 
the west in terms of epidemiology, predisposing factors, microbiology, complications, and 
outcome.  Culture-negative endocarditis continues to have a high prevalence in developing 
countries like Pakistan, largely due to prior antibiotic use before clinical presentation. We 
believe that this practice may lead to a decreased sensitivity of the Duke criteria in 
diagnosing endocarditis. Further studies are needed to validate the negative predictive value 
of the Duke criteria in developing countries. Clinicians in countries like Pakistan should be 
advised to maintain a high index of suspicion of endocarditis and send blood cultures or refer 
appropriately before prescribing antibiotics. 
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Table 1: General characteristics of 159 patients with infective endocarditis, Pakistan 
1988-2001 
_____________________________________________________ 
 
Characteristic                                                                     Value 
_____________________________________________________ 
 
Number of patients        159 
 
Age in years (mean +/- SD*)                34.6 +/- 21.2 
 
Male:female ratio      103:56 
 
‘Definite endocarditis’                        95 (59.7) 
 
‘Possible endocarditis’                        64 (40.3) 
 
Nosocomial endocarditis (after > 72 hrs in-hospital)          5 (3) 
 
Acute endocarditis                 55 (34.5) 
 
Subacute endocarditis+             99 (62) 
____________________________________________________ 
 
*  SD = standard deviation 
+   Subacute endocarditis defined as symptoms >10 days. 
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Table 2: Predisposing factors in 159 patients with infective endo-carditis 
______________________________________________________ 
 
Predisposing factor    No. of patients (%) 
______________________________________________________ 
 
Congenital heart disease (CHD)   39  (25) 
    Cyanotic congenital heart disease  6  (15) 
    Teratology of Fallot     3    (8) 
    Transposition of great arteries  2    (5) 
    Supraventricular pulmonary stenosis   1    (3) 
    Acyanotic congenital heart disease  33  (85) 
    Ventricular septal defect   14  (36) 
    Atrioventricular cushion defects  3    (8) 
    Patent ductus arteriosus   2    (5) 
    Atrial septal defect    2    (5) 
    Bicuspid aortic valve    4  (10) 
    Coarctation of aorta    1    (3) 
    Cleft mitral valve    1    (3) 
    Congenital mitral stenosis   1    (3) 
    Others     5  (12) 
    Surgically-corrected CHD    7  (18)  
Rheumatic heart disease (RHD)   34  (21) 
    Mitral valve     16  (47) 
    Aortic valve     11  (32) 
    Aortic and mitral valve    2    (6) 
    Pulmonic valve     1    (3) 
    Undetermined                                        4  (12) 
    Surgically-treated RHD   1    (3) 
IV drug user     1    (1) 
Mitral valve prolapse with murmur  10    (6) 
Prosthetic valve     8    (5) 
Degenerative/stenotic aortic disease  2    (1) 
Indwelling dialysis catheter      2    (1) 
No predisposing factors    65  (41) 
_______________________________________________________ 
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Table 3: Microorganisms recovered from blood cultures of patients with infective endocarditis 
______________________________________________________ 
 
Organism      No. of patients (%)       
______________________________________________________ 
 
GRAM-POSITIVE 
 
Streptococci     38 (23) 
     viridans Streptococci    24 (15) 
     Streptococcus bovis    1 (1) 
     Streptococcus mitis    1 (1) 
     Streptococcus intermedius   1 (1) 
     Others     11 (7) 
 
Staphylococci     21 (13) 
     Staphylococcus aureus   10 (6) 
     Staphylococcus epidermidis    11 (7) 
 
Enterococcus faecalis    7 (4) 
 
GRAM-NEGATIVE 
 
Pseudomonas species*    3 (2) 
Enterobacter+     3 (2) 
Serratia      1 (1) 
 
 
No growtha     86 (54) 
______________________________________________________  
 
*   P. cepaciae and P. maltophilia. 
+  Enterobacter cloacae and E. agglomerans. 
a   At least three (3) blood cultures. 
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Table 4: Echocardiographic findings in patients with endocarditis 
_____________________________________________________ 
 
Finding          No. of patients (%) 
_____________________________________________________ 
 
Site of involvement*        
 
     Mitral valve                    71  (45) 
     Aortic valve                    52  (33) 
     Tricuspid valve           9    (6) 
     Pulmonic valve           4    (3) 
     Ventricular septal defect          8    (5) 
 
Other findings 
 
Moderate to severe valvular insufficiency          80  (49) 
Mobile vegetation                     43  (27) 
Large vegetation+                     20  (13) 
Perivalvular abscess                       4    (2) 
Intramyocardial abscess             1    (1) 
Sinus of valsalva aneurysm                         1    (1) 
_____________________________________________________ 
 
*  Includes patients with multi-valvular involvement. 
+  >10 mm in size. 
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Table 5: Complications and mortality observed in patients with infective endocarditis 
___________________________________________________ 
             
Complications      No. of patients (%) 
___________________________________________________ 
 
Died                 37 (23) 
 
Surgery required                18 (11) 
 
Neurologic complications              41 (26) 
     Stroke                23 (15) 
     Intracranial hemorrhage     6   (4) 
     Seizures       7   (4) 
     Meningitis                                                           4   (3) 
     Brain abscess      1   (1) 
 
Renal complications               20 (13) 
     Renal insufficiency*               18 (11) 
     Interstitial nephritis      2   (1) 
     Glomerulonephritis      4   (2) 
 
Hemolysis                  20 (13) 
 
Cardiac         40 (25) 
     Heart failure                    35 (22) 
     Cardiac abscess+         5   (3) 
 
Peripheral embolism                   16 (10) 
 
Pneumonia                   13   (8)  
 Sepsis          7   (4) 
___________________________________________________ 
 
*  Serum creatinine > 2.0 mg/dL. 
+  Includes intramyocardial (1) and perivalvular (4) abscesses. 
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Table 6: Risk factors for mortality in patients with infective endocarditis 
____________________________________________________________ 
              Died            Recovered   
Characteristics    (n = 37)          (n = 122)      p value    95% CI 
____________________________________________________________ 
 
GENERAL   
   Age   37.6 +/- 22      33.7 +/- 21        NS*   -  
   Sex (M:F)       23/14  80/ 42           NS   -  
   Acute endocarditis+    13  (35)  42 (34)           NS   -  
   Prosthetic valve IE      5  (13)    3   (2)         0.017     1.4 - 27.3  
   Nosocomial       3    (8)   2   (2)         0.054   0.85 - 26.7  
   Culture-positive     15  (41) 58 (48)           NS   -  
   Definitive endocarditis    25  (67) 70 (57)           NS   - 
 
PRESENTATION 
   Fever      35  (95)         114 (93)           NS   - 
   Splenomegaly       8  (22) 20 (16)           NS   -  
   Anemia      20  (54) 65 (53)           NS   -  
   Thrombocytopenia      4  (11) 16 (13)           NS   -  
   Leukocytosis       8  (21) 38 (31)           NS   -  
  
PREDISPOSING FACTORS 
   Rheumatic heart disease      7  (19) 27 (22)           NS   - 
   Congenital heart disease     9  (24) 30 (25)           NS   -  
   MVP with murmur      1    (3)   9   (7)           NS   -  
   Intravenous drug use      0    (0)   1   (1)           NS   -  
   Previous cardiac surgery   8  (21) 12 (10)        0.055     0.95-6.75  
 
MICROBIOLOGY 
   Streptococci       2    (5)   9   (6)           NS   -  
   Staphylococcus aureus      3    (8)   7   (6)           NS            - 
   Pseudomonas spp      2    (5)   1   (1)           NS             - 
   Enterococci       2    (5)   7   (6)           NS   -  
 
COMPLICATIONS 
   Neurologic complications 18  (48) 23 (18)     < 0.001    1.85 - 8.9 
   Renal failureo       9  (24)   9   (7)        0.004    1.44 - 11.1          
   Hemolysis       5  (14)   6   (5)          0.07            - 
   Peripheral embolism      7  (19)   9   (7)        0.056    0.94 - 9.8  
   Heart failure     16  (43) 19 (16)     < 0.001    1.83 - 9.3 
   Cardiac abscess       2    (5)   3   (3)           NS             -  
   Large vegetationa      5  (14) 15 (12)           NS             -  
   Pneumonia       5  (14)   8   (7)           NS             -  
   Sepsis        4  (11)   3   (2)         0.03       .02 - 22.5  
   Surgery for endocarditis      3    (8) 15 (12)           NS   - 
___________________________________________________________________ 
      *    Not significant. 
      +    Defined as symptoms <10 days. 
      o    Serum creatinine >2 mg/dL.               
      a    >10 mm in size.    
